FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to chemical-pharmaceutical industry, and concerns a pharmaceutical composition containing: a) one or more NO-release NSAIDs of formula (I) ; b) one or more surface-active substances; a) a carbonyl radical acceptor compound specified in free acid forms, salts, ester derivatives of carboxylic acid of the compound of formula (II): H2N-(CH2)m-(C6H4)-COOH, where m=0-10; and d) if necessary, an oil or lard and/or short-link fat.
EFFECT: compositions exhibit high storage stability.
15 cl, 3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
NEW SELF-EMULSIFYING SYSTEM FOR DELIVERY OF DRUGS | 2001 |
|
RU2270675C9 |
NEW SELF-EMULSIFIED DRUG DELIVERY SYSTEM | 2001 |
|
RU2275908C2 |
FAST DISPERSING GELATIN-COATED TABLETS | 2005 |
|
RU2367413C2 |
CAPSULES CONTAINING WATER FILLING COMPOSITIONS, STABILISED WITH DERIVATIVE OF CYCLODEXTRIN | 2003 |
|
RU2359698C2 |
SOLID DOSED OUT FORMS INCLUDING FIBRAT AND STATIN | 2004 |
|
RU2343905C2 |
ORAL GALENICS WITH RAPID RELEASE AND SUSTAINED-RELEASE COMPRISING ABSORPTION-ENHANCING AGENT AND APPLICATION OF THIS ABSORPTION-ENHANCING AGENT | 1999 |
|
RU2228201C2 |
DOSAGE FORMS IN FORM OF CAPSULES | 2019 |
|
RU2824998C2 |
ORAL PHARMACEUTICAL FORMS OF LIQUID DRUGS SHOWING IMPROVED BIOAVAILABILITY | 2003 |
|
RU2323003C2 |
SOLID COMPOSITIONS CONTAINING 5-AMINOLEVULINIC ACID | 2010 |
|
RU2527328C2 |
PHARMACEUTICAL DRUG | 2019 |
|
RU2795027C2 |
Authors
Dates
2010-12-20—Published
2006-06-29—Filed